Výsledky vyhledávání

Akademický článek

Primary hyperparathyroidism in young patients is associated with metabolic disorders: a prospective comparative study.

Autor: Bibik EE; Department of Parathyroid Pathology and Mineral Disorders, Endocrinology Research Centre, Dm. Ulyanova St., 11, Moscow, 117036, Russia. bibik.ekaterina@endocrincentr.ru., Dobreva EA; Department of Parathyroid Pathology and Mineral Disorders, Endocrinology Research Centre, Dm. Ulyanova St., 11, Moscow, 117036, Russia., Elfimova AR; Department of Parathyroid Pathology and Mineral Disorders, Endocrinology Research Centre, Dm. Ulyanova St., 11, Moscow, 117036, Russia., Miliutina AP; Department of Registers of Endocrinopathies, Endocrinology Research Centre, Dm. Ulyanova St., 11, Moscow, 117036, Russia., Eremkina AK; Department of Parathyroid Pathology and Mineral Disorders, Endocrinology Research Centre, Dm. Ulyanova St., 11, Moscow, 117036, Russia., Gorbacheva AM; Department of Parathyroid Pathology and Mineral Disorders, Endocrinology Research Centre, Dm. Ulyanova St., 11, Moscow, 117036, Russia., Krupinova JA; Department of Parathyroid Pathology and Mineral Disorders, Endocrinology Research Centre, Dm. Ulyanova St., 11, Moscow, 117036, Russia., Koksharova EO; Laboratory of Clamp-Technology, Endocrinology Research Centre, Dm. Ulyanova St., 11, Moscow, 117036, Russia., Sklyanik IA; Laboratory of Clamp-Technology, Endocrinology Research Centre, Dm. Ulyanova St., 11, Moscow, 117036, Russia., Mayorov AY; Laboratory of Clamp-Technology, Endocrinology Research Centre, Dm. Ulyanova St., 11, Moscow, 117036, Russia., Mokrysheva NG; Endocrinology Research Centre, Dm. Ulyanova St., 11, Moscow, 117036, Russia.

Publikováno v: BMC endocrine disorders [BMC Endocr Disord] 2023 Mar 09; Vol. 23 (1), pp. 57. Date of Electronic Publication: 2023 Mar 09.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

The efficacy and safety of GP40081 (insulin aspart biphasic 30) compared with NovoMix ^® 30 in Type 2 diabetes patients.

Autor: Drai RV; R&D Center, GEROPHARM, Degtyarny Lane 11B, St. Petersburg, 191144, Russia., Mayorov AY; Endocrinology Research Centre, Dm. Ulyanova Street 11, Moscow, 117036, Russia., Karonova TL; Institute of Endocrinology, Almazov National Medical Research Center, Akkuratova Street 2, St. Petersburg, 197341, Russia., Parfenova TM; Krasnoyarsk State Medical University named after Prof. V.F. Voyno-Yasenetskiy, Partizana Zheleznyaka Street 1, Krasnoyarsk, 660022, Russia., Makarenko IE; R&D Center, GEROPHARM, Degtyarny Lane 11B, St. Petersburg, 191144, Russia., Magruk MA; R&D Center, GEROPHARM, Degtyarny Lane 11B, St. Petersburg, 191144, Russia., Alpenidze DN; City Polyclinic No. 117, Simonova Street 5/1, St. Petersburg, 194358, Russia., Kovalik VV; R&D Center, GEROPHARM, Degtyarny Lane 11B, St. Petersburg, 191144, Russia., Zinnatulina BR; R&D Center, GEROPHARM, Degtyarny Lane 11B, St. Petersburg, 191144, Russia., Grigorjeva IV; R&D Center, GEROPHARM, Degtyarny Lane 11B, St. Petersburg, 191144, Russia., Andreeva AT; Institute of Endocrinology, Almazov National Medical Research Center, Akkuratova Street 2, St. Petersburg, 197341, Russia.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2022 Dec; Vol. 11 (18), pp. 1337-1347. Date of Electronic Publication: 2022 Dec 13.

Zobrazit plný text záznamu

Akademický článek

Clinical Pharmacology of Insulin Aspart Biosimilar GP40071: Pharmacokinetic/Pharmacodynamic Comparability in Hyperinsulinemic Euglycemic Clamp Procedure.

Autor: Drai RV; R&D center, GEROPHARM, Saint-Petersburg, Russia., Karonova TL; Institute of Endocrinology, Almazov National Medical Research Center, Saint Petersburg, Russia., Mayorov AY; Endocrinology Research Centre, Moscow, Russia., Makarenko IE; R&D center, GEROPHARM, Saint-Petersburg, Russia., Dorotenko AR; R&D center, GEROPHARM, Saint-Petersburg, Russia., Kulesh VS; R&D center, GEROPHARM, Saint-Petersburg, Russia., Kovalik VV; R&D center, GEROPHARM, Saint-Petersburg, Russia., Andreeva AT; Endocrinology Research Centre, Moscow, Russia.

Publikováno v: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2022 Aug; Vol. 11 (8), pp. 922-929. Date of Electronic Publication: 2022 Mar 01.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

[The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities].

Autor: Maevskaya MV; Sechenov First Moscow State Medical University (Sechenov University)., Kotovskaya YV; Russian Clinical and Research Center of Gerontology of Pirogov Russian National Research Medical University., Ivashkin VT; Sechenov First Moscow State Medical University (Sechenov University)., Tkacheva ON; Russian Clinical and Research Center of Gerontology of Pirogov Russian National Research Medical University., Troshina EA; Endocrinology Research Centre., Shestakova MV; Endocrinology Research Centre., Breder VV; Blokhin National Medical Research Center of Oncology., Geyvandova NI; Stavropol State Medical University., Doshchitsin VL; Pirogov Russian National Research Medical University., Dudinskaya EN; Russian Clinical and Research Center of Gerontology of Pirogov Russian National Research Medical University., Ershova EV; Endocrinology Research Centre., Kodzoeva KB; Sechenov First Moscow State Medical University (Sechenov University)., Komshilova KA; Endocrinology Research Centre., Korochanskaya NV; Kuban State Medical University., Mayorov AY; Endocrinology Research Centre., Mishina EE; Endocrinology Research Centre., Nadinskaya MY; Sechenov First Moscow State Medical University (Sechenov University)., Nikitin IG; Pirogov Russian National Research Medical University.; National Medical Research Center 'Treatment and Rehabilitation Center'., Pogosova NV; National Medical Research Center of Cardiology., Tarzimanova AI; Sechenov First Moscow State Medical University (Sechenov University)., Shamkhalova MS; Endocrinology Research Centre.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2022 Feb 15; Vol. 94 (2), pp. 216-253. Date of Electronic Publication: 2022 Feb 15.

Zobrazit plný text záznamu

Akademický článek

Safety and efficacy of GP40071 compared with originator insulin aspart (NovoRapid ^® Penfill ^® ) in Type 1 diabetes mellitus.

Autor: Karonova TL; Institute of Endocrinology, Almazov National Medical Research Center, Saint Petersburg, Russia., Mayorov AY; Department of Endocrinology, Endocrinology Research Centre, Moscow, Russia., Magruk MA; Clinical Trial Department, R&D Center, GEROPHARM, Saint-Petersburg, Russia., Zyangirova ST; Department of Endocrinology, Kazan Endocrinology Center, Kazan, Russia., Grigoryeva IV; Clinical Trial Department, R&D Center, GEROPHARM, Saint-Petersburg, Russia., Khmelnitski OK; Department of Therapy, Saint-Petersburg University, Saint-Petersburg, Russia., Myshkovets A; Clinical Trial Department, R&D Center, GEROPHARM, Saint-Petersburg, Russia., Parfenova TM; Krasnoyarsk State Medical University named after Professor VF Voyno-Yasenetskiy, Krasnoyarsk, Russia., Mosikian AA; Clinical Trial Department, R&D Center, GEROPHARM, Saint-Petersburg, Russia., Drai RV; Clinical Trial Department, R&D Center, GEROPHARM, Saint-Petersburg, Russia.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2021 Jun; Vol. 10 (9), pp. 763-775. Date of Electronic Publication: 2021 Apr 30.

Zobrazit plný text záznamu

Akademický článek

Identifying the unmet needs of individuals with Type 2 diabetes: an international web-based survey.

Autor: Raposo JF; NOVA Medical School/FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; Associação Protectora dos Diabéticos de Portugal (APDP), 118 to 120 Rua do Salitre, Lisbon 1250-203, Portugal., Shestakova MV; Institute, Endocrinology Research Centre, Diabetes Institute, Moscow, Russian Federation.; National Research Centre for Endocrinology, Moscow, Russian Federation., Lu J; Department of Endocrinology, Chinese PLA General Hospital, Beijing, China., Court E; Servier, Global Business Excellence, Suresnes, France., Mayorov AY; Institute, Endocrinology Research Centre, Diabetes Institute, Moscow, Russian Federation.; National Research Centre for Endocrinology, Moscow, Russian Federation.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2021 May; Vol. 10 (7), pp. 613-624. Date of Electronic Publication: 2021 Mar 26.

Zobrazit plný text záznamu

Akademický článek

[The prospects for the creation of the National Center for Personalized Medicine of Endocrine Diseases].

Autor: Dedov II; Endocrinology Research Centre., Mokrysheva NG; Endocrinology Research Centre., Shestakova MV; Endocrinology Research Centre., Volchkov PY; Endocrinology Research Centre., Mayorov AY; Endocrinology Research Centre., Rebrova OY; Endocrinology Research Centre., Barysheva VO; Endocrinology Research Centre., Krupinova JA; Endocrinology Research Centre., Troshina EA; Endocrinology Research Centre., Dzeranova LK; Endocrinology Research Centre., Melnichenko GA; Endocrinology Research Centre.

Publikováno v: Problemy endokrinologii [Probl Endokrinol (Mosk)] 2021 Jan 26; Vol. 67 (1), pp. 13-19. Date of Electronic Publication: 2021 Jan 26.

Zobrazit plný text záznamu

Akademický článek

Efficacy and safety of GP40021 insulin lispro biphasic compared with Humalog Mix 25 in Type 2 diabetes mellitus patients.

Autor: Mayorov AY; Diabetes institution, Endocrinology Research Centre, Moscow, Russia., Mosikian AA; Department of Clinical trial, OOO GEROPHARM, Saint Petersburg, Russia., Alpenidze DN; Department of Endocrinology, City Outpatient Clinic No. 117, Saint Petersburg, Russia., Makarenko IE; Department of Clinical trial, OOO GEROPHARM, Saint Petersburg, Russia., Orlova VL; Department of Endocrinology, City Hospital No. 2, Saint Petersburg, Russia., Lunev IS; Department of Clinical trial, OOO GEROPHARM, Saint Petersburg, Russia., Verbovaya MV; Department of Endocrinology, Diabetes Center Ltd, Samara, Russia., Zinnatulina BR; Department of Clinical trial, OOO GEROPHARM, Saint Petersburg, Russia., Khokhlov AL; The Chair of Clinical Pharmacology, Yaroslavl State Medical University, Yaroslavl, Russia., Drai RV; Department of Clinical trial, OOO GEROPHARM, Saint Petersburg, Russia.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2021 Jan; Vol. 10 (1), pp. 55-66. Date of Electronic Publication: 2020 Dec 23.

Zobrazit plný text záznamu

Akademický článek

Safety and efficacy of GP40061 compared with originator insulin glargine (Lantus ^® ): a randomized open-label clinical trial.

Autor: Karonova TL; Institute of Endocrinology, Almazov National Medical Research Center, Saint-Petersburg, Russia., Mosikian AA; Clinical Trials Department, OOO GEROPHARM, Saint-Petersburg, Russia., Mayorov AY; Diabetes Prognosis and Innovation Department, Endocrinology Research Centre, Moscow, Russia., Makarenko IE; Clinical Trials Department, OOO GEROPHARM, Saint-Petersburg, Russia., Zyangirova ST; Kazan Endocrine Center, Kazan, Russia., Afonkina OA; Clinical Trials Department, OOO GEROPHARM, Saint-Petersburg, Russia., Belikova TM; Clinical Trials Department, OOO GEROPHARM, Saint-Petersburg, Russia., Zalevskaya AG; Department of Endocrinology, First Pavlov State Medical University, Saint-Petersburg, Russia., Khokhlov AL; Clinical Pharmacology Department, Yaroslavl State Medical University, Yaroslavl, Russia., Drai RV; Clinical Trials Department, OOO GEROPHARM, Saint-Petersburg, Russia.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2020 Mar; Vol. 9 (4), pp. 263-273. Date of Electronic Publication: 2020 Feb 06.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání